Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISTH 2022 | Managing pregnant women with vWD

Susan Halimeh • 11 Jul 2022
ISTH 2022
Non-Malignant Von Willebrand Disease

Susan Halimeh, MD, Gerinnungszentrum Rhein-Ruhr, Duisburg, Germany, outlines the challenges associated with managing pregnant women with von Willebrand disease (vWD). This interview took place at the 30th Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2022 held in London, UK.

More from Susan Halimeh

0:44
Simoctocog alfa for the treatment of patients with hemophilia A
Susan Halimeh • 11 Jul 2022
1:09
Highlights from ISTH: gene therapy in hemophilia A & undiagnosed bleeding disorders in pediatrics
Susan Halimeh • 11 Jul 2022
0:51
Intramuscular COVID-19 vaccination in patients with severe hemophilia A
Susan Halimeh • 11 Jul 2022
1:23
Challenges in vWD: new guidelines & managing women with vWD
Susan Halimeh • 12 Jul 2022

Related Videos

2:38
Treosulfan vs busulfan conditioning in pediatric patients with non-malignant diseases
Rita Beier • 15 Apr 2024
2:18
A global view of transfusion-dependent thalassemia: standard of care, outcomes, and unmet needs
Ali Taher • 15 Apr 2024
1:24
The future of CAR T-reg cells: organ transplantation & autoimmune disease
Zinaida Good • 9 Apr 2024
1:23
Developing a PRO collection tool for patients with SCD: key themes which are important to patients
Nirmish Shah • 8 Dec 2023
The content of VJHemOnc is intended for healthcare professionals